It's no better over on iQuack Hub, where all of the recent company comments and analyses by the unlicensed doctor has been pretty lacking. Perhaps he's been hired to provide stock analysis for Quack Investor magazine. That would explain all the futile arm flapping going on while Amarantus continues to move towards becoming a world-class biotech company.

    PREVIOUS JOB                                CURRENT JOB